REX trades 52.4% below Wall Street's consensus target of $60.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes REX achieves its forward estimates and maintains a stable P/E multiple of 50.8x. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, REX American Resources Corporation (REX) has a Wall Street consensus price target of $60.00, based on estimates from 3 covering analysts. With the stock currently trading at $39.38, this represents a potential upside of +52.4%. The company has a market capitalization of $1.30B.
Analyst price targets range from a low of $60.00 to a high of $60.00, representing a 0% spread in expectations. The median target of $60.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, REX trades at a trailing P/E of 10.8x and forward P/E of 50.8x. The forward PEG ratio of 0.67 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -78.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $37.73, with bear and bull scenarios of $23.77 and $49.71 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 GPREGreen Plains Inc. | $926M | $13.23 | $20.00 | +51.2% | Buy | 6.2x | 20 |
 ANDEThe Andersons, Inc. | $1.9B | $55.12 | $96.67 | +75.4% | Buy | 10.0x | 22 |
 BIOXBioceres Crop Solutions Corp. | $15M | $0.23 | — | — | — | — | — |
 ADMArcher-Daniels-Midland Company | $33.7B | $69.97 | $84.75 | +21.1% | Hold | 12.6x | 36 |
 BGBunge Global S.A. | $19.0B | $99.10 | $152.50 | +53.9% | Buy | 10.5x | 25 |
 MGPIMGP Ingredients, Inc. | $364M | $16.98 | $25.50 | +50.2% | Buy | 10.2x | 10 |
 DEDeere & Company | $181.3B | $671.65 | $731.20 | +8.9% | Buy | 37.2x | 46 |
 CFCF Industries Holdings, Inc. | $18.3B | $119.39 | $128.00 | +7.2% | Buy | 7.9x | 43 |
 MOSThe Mosaic Company | $7.1B | $22.36 | $24.70 | +10.5% | Hold | 65.1x | 49 |
 UANCVR Partners, LP | $1.2B | $109.48 | — | — | Hold | 7.9x | 6 |
Quick answers to the most common questions about buying REX stock.
The consensus Wall Street price target for REX is $60, representing 52.4% upside from the current price of $39.38. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
REX has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $60 implies 52.4% upside from current levels.
At a forward P/E of 50.8129x, REX trades at a premium valuation. The consensus price target of $60 (52.4% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $60 for REX, while the most conservative target is $60. The consensus of $60 represents the median expectation. Our quantitative valuation model projects a bull case target of $50 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
REX is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month REX stock forecast based on 3 Wall Street analysts shows a consensus price target of $60, with estimates ranging from $60 (bear case) to $60 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $38, with bear/bull scenarios of $24/$50.
Our quantitative valuation model calculates REX's fair value at $38 (base case), with a bear case of $24 and bull case of $50. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
REX trades at a forward P/E ratio of 50.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 10.8x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on REX, with a "Buy" consensus rating and $60 price target (52.4% upside). 3 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
REX analyst price targets range from $60 to $60, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $60 consensus represents the middle ground. Our model's $24-$50 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.